Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Typical study doses range 13 g/day
Discuss with your provider before your reauthorization date
Weight Monitoring Strategies Weigh yourself consistentlyideally at the same time of day, wearing similar clothing, using the same scale
View on PubMed Retatrutide in Type 2 Diabetes with Inadequate Glycaemic Control: Phase 3 Trial (TRANSCEND-T2D-1) Phase 3 double-blind RCT confirming retatrutide produces significant HbA1c reduction and body weight loss in adults with type 2 diabetes, establishing its dual metabolic benefit across glycaemic control and body composition in a large clinical trial (Lancet, 2026)
Treatment Goals Aggressive goals may require higher doses or longer treatment duration
Youre not on your own, were here to make this work for your life and schedule
US$ 20.39
US$ 20.76
US$ 22.60
US$ 27.90
US$ 22.74
US$ 26.74
